In Brief: Procter & Gamble
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble: Submits comments on FDA's proposed nutrient content and health claims regs ("The Tan Sheet" Jan. 1, p. 15). Referring to the agency's proposal to allow unlisted synonyms on labeling as long as the approved term also appears. P&G recommended that "FDA adopt a more flexible policy by making the use of the approved term optional" because "use of two nutrient content claims may make the label crowded and confusing to consumers." The comments suggest making use of the listed synonym an optional safe harbor...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning